Columbia Care Inc. said Thursday its fourth-quarter net loss widened to $53.3 million, or 14 cents a share, from a loss of $43.3 million, or 16 cents a share in the year-ago quarter. The cannabis company’s revenue increased to $139.3 million from $76.1 million. Analysts expected Columbia Care to lose five cents a share on revenue of $138.3 million, according to FactSet data. Looking ahead, Columbia Care expects 2022 revenue of $625 million to $675 million, below the analyst target of $692.4 million. Shares of Columbia Care are up 7% so far in 2022, compared to a loss of 20.7% by the AdvisorShares Pure U.S. Cannabis ETF . Columbia Care on Wednesday announced it was being acquired by Cresco Labs Inc. for $2 billion in stock.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
